Guardian Pharmacy Services, Inc. (NYSE:GRDN – Get Free Report) passed above its 50 day moving average during trading on Wednesday. The stock has a 50 day moving average of $41.28 and traded as high as $43.10. Guardian Pharmacy Services shares last traded at $42.0350, with a volume of 658,227 shares traded.
Analyst Upgrades and Downgrades
Several research firms recently weighed in on GRDN. Weiss Ratings cut shares of Guardian Pharmacy Services from a “buy (b)” rating to a “buy (b-)” rating in a research report on Friday, October 23rd. Wall Street Zen lowered shares of Guardian Pharmacy Services from a “buy” rating to a “hold” rating in a report on Sunday, October 25th. Oppenheimer raised their target price on shares of Guardian Pharmacy Services from $43.00 to $49.00 and gave the company an “outperform” rating in a report on Friday, August 7th. KeyCorp started coverage on shares of Guardian Pharmacy Services in a research report on Tuesday, September 22nd. They issued an “overweight” rating and a $52.00 target price for the company. Finally, Truist Financial upped their price target on shares of Guardian Pharmacy Services from $47.00 to $51.00 and gave the stock a “buy” rating in a report on Monday, September 21st. Nine investment analysts have rated the stock with a Buy rating and one has given a Hold rating to the company’s stock. According to MarketBeat.com, Guardian Pharmacy Services presently has an average rating of “Moderate Buy” and a consensus price target of $45.57.
Read Our Latest Research Report on GRDN
Guardian Pharmacy Services Stock Up 2.9%
The business’s 50 day simple moving average is $41.28 and its two-hundred day simple moving average is $38.17. The stock has a market cap of $2.09 billion, a P/E ratio of 40.81, a PEG ratio of 2.13 and a beta of 0.06.
Guardian Pharmacy Services (NYSE:GRDN – Get Free Report) last announced its quarterly earnings results on Thursday, August 6th. The company reported $0.29 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.26 by $0.03. Guardian Pharmacy Services had a net margin of 4.50% and a return on equity of 29.97%. The company had revenue of $351.77 million during the quarter, compared to the consensus estimate of $340.45 million. As a group, research analysts forecast that Guardian Pharmacy Services, Inc. will post 1.18 earnings per share for the current fiscal year.
Institutional Investors Weigh In On Guardian Pharmacy Services
Hedge funds and other institutional investors have recently bought and sold shares of the company. Nisa Investment Advisors LLC increased its holdings in Guardian Pharmacy Services by 53.5% in the 3rd quarter. Nisa Investment Advisors LLC now owns 1,050 shares of the company’s stock worth $43,000 after purchasing an additional 366 shares in the last quarter. State of Alaska Department of Revenue boosted its stake in shares of Guardian Pharmacy Services by 105.9% during the third quarter. State of Alaska Department of Revenue now owns 2,390 shares of the company’s stock valued at $97,000 after purchasing an additional 1,229 shares in the last quarter. VIRGINIA RETIREMENT SYSTEMS ET Al boosted its stake in shares of Guardian Pharmacy Services by 17.5% during the third quarter. VIRGINIA RETIREMENT SYSTEMS ET Al now owns 9,400 shares of the company’s stock valued at $383,000 after purchasing an additional 1,400 shares in the last quarter. Bank of New York Mellon Corp grew its holdings in shares of Guardian Pharmacy Services by 3.2% during the first quarter. Bank of New York Mellon Corp now owns 69,432 shares of the company’s stock worth $2,615,000 after purchasing an additional 2,177 shares during the last quarter. Finally, Park Avenue Securities LLC grew its holdings in shares of Guardian Pharmacy Services by 12.6% during the third quarter. Park Avenue Securities LLC now owns 20,863 shares of the company’s stock worth $851,000 after purchasing an additional 2,338 shares during the last quarter.
Guardian Pharmacy Services Company Profile
Guardian Pharmacy Services, Inc is a provider of pharmacy services focused primarily on residents of long-term care and other institutional healthcare settings. Through its network of pharmacies, the company supplies prescription medications and related pharmacy support to assisted living communities, skilled nursing facilities, behavioral health organizations, and other care providers.
The company’s services include medication dispensing and packaging, prescription delivery, medication management, clinical pharmacy support, and technology-enabled tools designed to help caregivers and healthcare professionals manage residents’ medication regimens.
Read More
- Five stocks we like better than Guardian Pharmacy Services
- How Much of Tesla’s Robotaxi Future Is Already Priced In?
- 3 AI Infrastructure Plays Beyond Chipmakers
- Keurig Dr Pepper’s Beverage Growth Raises a Tough Question About Its Coffee Split
- Why ExxonMobil and Chevron Reminded Investors to Keep it Simple
Receive News & Ratings for Guardian Pharmacy Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Guardian Pharmacy Services and related companies with MarketBeat.com's FREE daily email newsletter.
